Corrigendum to “Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial” [Contemp Clin Trials 2024 Apr:139:107456, pgs 1–11]

IF 2 3区医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL

Contemporary clinical trials Pub Date : 2025-02-01 DOI:10.1016/j.cct.2024.107767

James D. Ralston , Melissa Anderson , Janet Ng , Ayat Bashir , Kelly Ehrlich , Dena Burns-Hunt , Meredith Cotton , Laurel Hansell , Clarissa Hsu , Helen Hunt , Andrew J. Karter , Shaula M. Levy , Evette Ludman , Lawrence Madziwa , Emily M. Omura , Kristine Rogers , Brandie Sevey , James A.M. Shaw , Susan M. Shortreed , Umesh Singh , Laura Yarborough

引用次数: 0

查看原文本刊更多论文

“预防成人2型糖尿病（PHT2）的严重低血糖：一项随机对照试验的设计、交付和评估框架”的更正[contemporary clinical Trials 2024年4月：139:107456，p1 -11]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Contemporary clinical trials 医学-药学

CiteScore

3.70

自引率

4.50%

发文量

281

审稿时长

44 days

期刊介绍： Contemporary Clinical Trials is an international peer reviewed journal that publishes manuscripts pertaining to all aspects of clinical trials, including, but not limited to, design, conduct, analysis, regulation and ethics. Manuscripts submitted should appeal to a readership drawn from disciplines including medicine, biostatistics, epidemiology, computer science, management science, behavioural science, pharmaceutical science, and bioethics. Full-length papers and short communications not exceeding 1,500 words, as well as systemic reviews of clinical trials and methodologies will be published. Perspectives/commentaries on current issues and the impact of clinical trials on the practice of medicine and health policy are also welcome.